UBS’s Regeneron Pharmaceuticals REGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2014
Q3
$19.6M Buy
54,404
+8,300
+18% +$2.99M 0.01% 741
2014
Q2
$13M Sell
46,104
-24,461
-35% -$6.91M 0.01% 924
2014
Q1
$21.2M Buy
70,565
+1,059
+2% +$318K 0.02% 622
2013
Q4
$19.1M Sell
69,506
-13,037
-16% -$3.59M 0.02% 627
2013
Q3
$25.8M Buy
82,543
+14,714
+22% +$4.6M 0.03% 483
2013
Q2
$15.3M Buy
+67,829
New +$15.3M 0.02% 620